Article info
PDFNeurodegeneration
Original research
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
- Correspondence to Professor Markus Otto, Neurology, University of Ulm, Ulm, Germany and Department of Neurology, University clinic, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; markus.otto{at}uk-halle.de
Citation
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
Publication history
- Received May 13, 2021
- Accepted July 26, 2021
- First published August 20, 2021.
Online issue publication
February 19, 2024
Article Versions
- Previous version (24 April 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.